Corrigendum to "Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen" [Bioorg. Med. Chem. Lett. 17 (2007) 4504] (DOI:10.1016/j.bmcl.2007.06.003);Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives of naproxen

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 16, 2007, Pages 4504-4508

  Amir, Mohammad ^a   Kumar, Harish ^a   Javed, Sadique A ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Analgesic; Anti inflammatory; Lipid peroxidation; Triazolo thiadiazoles; Ulcerogenic

Indexed keywords

4 AMINO [1 (6 METHOXY 2 NAPHTHYL)ETHYL] 3 MERCAPTO (4H) 1,24 TRIAZOLE; 6 2,2,4 TRIAZOLO[3,4B] 1,3,4 THIADIAZOLE DERIVATIVE; AROMATIC CARBOXYLIC ACID; ISOTHIOCYANIC ACID; NAPROXEN; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS;

EID: 34447307646     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.05.064     Document Type: Erratum

References (37)

1. Hla T., and Neilson K. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7384
2. Marnett L., and Kalgutkar A.S. Trend. Pharmacol. Sci. 20 (1999) 465
3. Dannhardt G., and Kiefer W. Eur. J. Med. Chem. 36 (2001) 109
4. Almansa C., Alfon J., De Arriba A., Cavalcanti F., Escamilla I., Gomez L., Miralles A., Soliva R., Bartolli J., Carceller E., Merlos M., and Garcia-Rafanell J. J. Med. Chem. 46 (2003) 3463
5. Jackson L., and Hawkey C. Exp. Opin. Invest. Drugs 8 (1999) 963
6. Allison M., Howatson A., Torrance C., Lee F., and Russell R. N. Engl. J. Med. 327 (1992) 749
7. Kalgutkar A.S. Exp. Opin. Invest. Drugs 9 (1999) 831
8. Tally J.J., Bertenshaw R.S., Brown D.L., Carter J.S., Graneto M.J., Kellogg M.S., Kobolt C.M., Yuan J., Zhang Y.Y., and Seibert K. J. Med. Chem. 43 (2000) 1661
9. Dange J.M., Supuran C.T., and Pravnito D. J. Med. Chem. 48 (2005) 2251
10. Galanakis D., Kourounakis A.P., Tsiakitzis K.C., Doulgkeris C., Rekka E.A., Gavalas A., Kravaritou C., Charitos C., and Kourounakis P.N. Bioorg. Med. Chem. Lett. 14 (2004) 3639
11. Kalgutkar A.S., Marnett A.B., Crews B.C., and Remmel R.P. J. Med. Chem. 43 (2000) 2860
12. Duflos M., Nourrisson M.R., Brelet J., Courant J., Le Baut G., Grimaud N., and Petit J.Y. Eur. J. Med. Chem. 36 (2001) 545
13. Kalgutkar A.S., Crews B., Rowlinson S., Garner C., Seibert K., and Marnett L. Science 280 (1998) 1268
14. Labanauskas L., Udrenaite E., Gaidelis P., and Brukstus A. Farmaco 59 (2004) 255
15. Mullican M., Wilson M., Commor D., Kostlan C., Schrier R., and Dyer R. J. Med. Chem. 36 (1993) 1090
16. Amir M., Khan M.S.Y., and Zaman M.S. Ind. J. Chem. B (2004) 2189
17. Schenone S., Brullo C., Bruno O., Bondavalli F., Ranise A., Filippelli W., Rinaldi B., Capuanob A., and Falconeb G. Bioorg. Med. Chem. 14 (2006) 1698
18. Palaska E., Sahin G., Kelicen P., Durlu N.T., and Altinok G. Farmaco 57 (2002) 101
19. Mathew V., Keshavayya J., and Vaidya V.P. Eur. J. Med. Chem. 41 (2006) 1048
20. Udupi H.R., Setty R.S., Srinivasullu N., Pasha Y.T., and Aggarwal N.K. Ind. J. Heterocycl. Chem. 12 (2003) 361
21. Amir M., and Kumar S. Archiv Der Pharmazie 338 (2005) 24
22. Amir M., and Kumar S. Die Pharmazie 60 (2005) 175
23. Amir M., and Kumar S. Acta Pharm. 57 (2007) 31
24. Synthesis of potassium dithiocarbazinate: potassium hydroxide (0.03 M) was dissolved in absolute ethanol (50 mL). The solution was cooled in ice bath and 6-methoxy-α-methyl-2-naphthalene acetic acid hydrazide (0.02 M) was added with stirring. To this carbondisulfide (0.025 M) was added in small portions with constant stirring. The reaction mixture was agitated continuously for 12 h at room temperature. The precipitated potassium dithiocarbazinate was collected by filtration, washed with anhydrous ether (100 mL) and dried in vacuum. The potassium salt thus obtained (65% yield) was used in the next step without further purification.
25. 4OS: C, 59.98; H, 5.37; N, 18.65; S, 10.61. Found: C, 59.96; H, 5.39; N, 18.62; S, 10.60.
26. General method for the synthesis of 3-[1-(6-methoxy-2-naphthyl)ethyl]-6-substituted[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles: an equimolar mixture of 4-amino-5-[1-(6-methoxy-2-naphthyl)ethyl]-3-mercapto-(4H)-1,2,4-triazole (0.10 M), aromatic acids (0.10 M) in phosphorus oxychloride (10 mL) was refluxed for 5 h. The reaction mixture was cooled to room temperature and then gradually poured onto crushed ice with stirring. The mixture was allowed to stand overnight and the solid separated out was filtered, treated with dilute sodium hydroxide solution and washed thoroughly with cold water, yield: 54-71%.
27. Rao A.S., Sudheendra, and Udupi R.H. Ind. J. Heterocycl. Chem. 15 (2006) 291
28. General method for the synthesis of 3-[1-(6-methoxy-2-naphthyl)ethyl]-6-alkyl/aryl amino[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles: an equimolar mixture of 4-amino-5-[1-(6-methoxy-2-naphthyl)ethyl]-3-mercapto-(4H)-1,2,4-triazole (0.10 M), aryl/alkyl isothiocyanate (0.10 M) in dimethylformamide (20 mL) was refluxed for 20-22 h. The reaction mixture was cooled to room temperature and then gradually poured onto crushed ice with stirring. The mixture was allowed to stand overnight, yield: 49-57%.
29. 5OS: C, 67.11; H, 5.40; N, 16.30; S, 7.46. Found: C, 67.10; H, 5.38; N, 16.33; S, 7.42.
30. Amir M., and Kumar S. Eur. J. Med. Chem. 39 (2004) 535
31. Adeyemi O.O., Okpo O.S., and Okpaka O. J. Ethnopharmacol. 90 (2004) 45
32. Cioli V., Putzolu S., Rossi V., Barcellona S.P., and Corradino C. Toxicol. Appl. Pharmacol. 50 (1979) 283
33. Ohkawa H., Ohishi N., and Yagi K. Anal. Biochem. 95 (1979) 351
34. Reitman S., and Frankel S. Am. J. Clin. Pathol. 28 (1957) 56
35. King E.J., and Armstrong A.R.A. Can. Med. Assoc. J. 31 (1934) 376
36. Varley H. Practical Clinical Biochemistry. 1st ed. (1988), CBS Publishers and Distributors, New Delhi pp 236
37. Luna L.G. Manual of Histological Staining Methods of the Armed Forces Institute of Pathology. 3rd ed. (1968), Mc-Graw-Hill, New York pp 567